Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry

Ding, Wern Yew ORCID: 0000-0003-3596-6545, Calvert, Peter, Gupta, Dhiraj, Huisman, Menno V and Lip, Gregory YH ORCID: 0000-0002-7566-1626 (2022) Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry. CLINICAL RESEARCH IN CARDIOLOGY, 111 (9). pp. 1057-1068.

Access the full-text of this item by clicking on the Open Access link.

Official URL: http://dx.doi.org/10.1007/s00392-022-02022-1

Abstract

<h4>Background</h4>First-line ablation for atrial fibrillation (AF) reduces the risk of recurrent atrial arrhythmias compared to medical therapy. However, the prognostic benefit of early AF ablation remains undetermined. Herein, we aimed to evaluate the effects of early AF ablation compared to medical therapy.<h4>Methods</h4>Using data from phase II/III of the GLORIA-AF registry, we studied patients who were consecutively enrolled with newly diagnosed AF (< 3 months before baseline visit) and an increased risk of stroke (CHA<sub>2</sub>DS<sub>2</sub>-VASc ≥ 1). At baseline visit, 445 (1.7%) patients were treated with early AF ablation and 25,518 (98.3%) with medical therapy. Outcomes of interest were the composite outcome of all-cause death, stroke and major bleeding, and pre-specified outcomes of all-cause death, cardiovascular (CV) death, non-CV death, stroke and major bleeding.<h4>Results</h4>A total of 25,963 patients (11733 [45.2%] females; median age 71 [IQR 64-78] years; 17424 [67.1%] taking non-vitamin K antagonist oral anticoagulants [NOACs]) were included. Over a follow-up period of 3.0 (IQR 2.3-3.1) years, after adjustment for confounders, early AF ablation was associated with a significant reduction in the composite outcome of all-cause death, stroke and major bleeding (HR 0.50 [95% CI 0.30-0.85]) and all-cause death (HR 0.45 [95% CI 0.23-0.91]). There were no statistical differences between the groups in terms of CV death, non-CV death, stroke and major bleeding. Similar results were obtained in a propensity-score matched analysis of patients with comparable baseline variables.<h4>Conclusions</h4>Early AF ablation in a contemporary prospective cohort of AF patients who were predominantly treated with NOACs was associated with a survival advantage compared to medical therapy alone.<h4>Trial registration</h4>Clinical trial registration: http://www.<h4>Clinicaltrials</h4>gov . Unique identifiers: NCT01468701, NCT01671007 and NCT01937377. Created with BioRender.com.

Item Type:	Article
Uncontrolled Keywords:	Early AF ablation, Long-term survival, Prognostic benefit, Newly diagnosed AF
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	06 Jul 2022 08:50
Last Modified:	18 Jan 2023 20:56
DOI:	10.1007/s00392-022-02022-1
Open Access URL:	https://doi.org/10.1007/s00392-022-02022-1
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3157857